The role of inflammation in schizophrenia

Ahuja, 2007, Possible anti-catatonic effects of minocycline in patients with schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, 31, 968, 10.1016/j.pnpbp.2007.01.018

Anderson, 2013, Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, 42, 1, 10.1016/j.pnpbp.2012.10.008

Anisman, 2003, Cytokines, stress and depressive illness: brain-immune interactions, Ann. Med., 35, 2, 10.1080/07853890310004075

Babulas, 2006, Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia, Am. J. Psychiatry, 163, 927, 10.1176/ajp.2006.163.5.927

Bechter, 2007, [Therapy-resistant depression with fatigue. A case of presumed streptococcal-associated autoimmune disorder], Nervenarzt., 338, 340, 10.1007/s00115-006-2178-8

Benros, 2012, Autoimmune diseases and infections as risk factors for schizophrenia, Ann. N. Y. Acad. Sci., 1262, 56, 10.1111/j.1749-6632.2012.06638.x

Benros, 2011, Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study, Am. J. Psychiatry, 168, 1303, 10.1176/appi.ajp.2011.11030516

Boksa, 2008, Maternal infection during pregnancy and schizophrenia, J. Psychiatry Neurosci., 33, 183

Brown, 2008, The risk for schizophrenia from childhood and adult infections, Am. J. Psychiatry, 165, 7, 10.1176/appi.ajp.2007.07101637

Brown, 2004a, Serologic evidence of prenatal influenza in the etiology of schizophrenia, Arch. Gen. Psychiatry, 61, 774, 10.1001/archpsyc.61.8.774

Brown, 2000, Nonaffective psychosis after prenatal exposure to rubella, Am. J. Psychiatry, 157, 438, 10.1176/appi.ajp.157.3.438

Brown, 2004b, Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring, Am. J. Psychiatry, 161, 889, 10.1176/appi.ajp.161.5.889

Brown, 2005, Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring, Am. J. Psychiatry, 162, 767, 10.1176/appi.ajp.162.4.767

Buka, 2008, Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring, Biol. Psychiatry, 63, 809, 10.1016/j.biopsych.2007.09.022

Buka, 2001, Maternal infections and subsequent psychosis among offspring, Arch. Gen. Psychiatry, 58, 1032, 10.1001/archpsyc.58.11.1032

Carlsson, 1988, The current status of the dopamine hypothesis of schizophrenia, Neuropsychopharmacology, 1, 179, 10.1016/0893-133X(88)90012-7

Ceresoli-Borroni, 2006, Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain, J. Neural Transm., 113, 1355, 10.1007/s00702-005-0432-z

Chakos, 2005, Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia, Br. J. Psychiatry, 186, 26, 10.1192/bjp.186.1.26

Chaudhry, 2012, Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment, J. Psychopharmacol., 26, 1185, 10.1177/0269881112444941

Chiveri, 2003, Schizophreniform disorder with cerebrospinal fluid PCR positivity for herpes simplex virus type 1, Eur. Neurol., 50, 182, 10.1159/000073062

Claes, 2011, The kynurenine pathway in major depression: haplotype analysis of three related functional candidate genes, Psychiatry Res., 188, 355, 10.1016/j.psychres.2011.03.012

Condray, 2011, 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia, Int. J. Neuropsychopharmacol., 14, 756, 10.1017/S1461145710001689

Cunningham, 2005, Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration, J. Neurosci., 25, 9275, 10.1523/JNEUROSCI.2614-05.2005

Dalman, 2008, Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects, Am. J. Psychiatry., 165, 59, 10.1176/appi.ajp.2007.07050740

Dantzer, 2001, Cytokine-induced sickness behavior: where do we stand?, Brain Behav. Immun., 15, 7, 10.1006/brbi.2000.0613

Doorduin, 2009, Neuroinflammation in schizophrenia-related psychosis: a PET study, J. Nucl. Med., 50, 1801, 10.2967/jnumed.109.066647

Ellman, 2010, Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8, Schizophr. Res., 121, 46, 10.1016/j.schres.2010.05.014

Erhardt, 2001, Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia, Neurosci. Lett., 313, 96, 10.1016/S0304-3940(01)02242-X

Felgenhauer, 1990, Psychiatric disorders in the encephalitic form of multiple sclerosis, J. Neurol., 237, 11, 10.1007/BF00319661

Frank, 2007, Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses, Brain Behav. Immun., 21, 47, 10.1016/j.bbi.2006.03.005

Furukawa, 1998, Interleukin-1, but not stress, stimulates glucocorticoid output during early postnatal life in mice, Ann. N. Y. Acad. Sci., 840, 117, 10.1111/j.1749-6632.1998.tb09555.x

Gattaz, 2004, Childhood meningitis, brain maturation and the risk of psychosis, Eur. Arch. Psychiatry Clin. Neurosci., 254, 23, 10.1007/s00406-004-0431-3

Genius, 2013, Glutamatergic dysbalance and oxidative stress in in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism, PLoS ONE, 8, e59395, 10.1371/journal.pone.0059395

Giovanoli, 2013, Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice, Science, 339, 1095, 10.1126/science.1228261

Godbout, 2009, Age and neuroinflammation: a lifetime of psychoneuroimmune consequences, Immunol. Allergy Clin. North Am., 29, 321, 10.1016/j.iac.2009.02.007

Goff, 2015, Drug development in schizophrenia: are glutamatergic targets still worth aiming at?, Curr. Opin. Psychiatry, 28, 207, 10.1097/YCO.0000000000000152

Gogtay, 2008, Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry, Proc. Natl. Acad. Sci. U.S.A., 105, 15979, 10.1073/pnas.0806485105

Green, 2014, Stress, schizophrenia and bipolar disorder, Curr. Top. Behav. Neurosci., 18, 217, 10.1007/7854_2014_290

Grüber, 2014, Adjunctive recombinant human interferon gamma-1b for treatment-resistant schizophrenia in 2 patients, J. Clin. Psychiatry, 75, 1266, 10.4088/jcp.14l09005

Hanson, 2005, Theories of schizophrenia: a genetic-inflammatory-vascular synthesis, BMC Med. Genet., 6, 7, 10.1186/1471-2350-6-7

Hayley, 2002, Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms, Eur. J. Neurosci., 15, 1061, 10.1046/j.1460-9568.2002.01936.x

Hiroshi, 2003, [An adult case suspected of recurrent measles encephalitis with psychiatric symptoms], Seishin Shinkeigaku Zasshi., 105, 1239

Hohlfeld, 2007, Dual role of inflammation in CNS disease, Neurology, 68, S58, 10.1212/01.wnl.0000275234.43506.9b

Howes, 2015, Glutamate and dopamine in schizophrenia: an update for the 21st century, J. Psychopharmacol., 29, 97, 10.1177/0269881114563634

Jarskog, 1997, Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro, Int. J. Dev. Neurosci., 15, 711, 10.1016/S0736-5748(97)00029-4

Job, 2006, Grey matter changes can improve the prediction of schizophrenia in subjects at high risk, BMC Med., 4, 29, 10.1186/1741-7015-4-29

Kabiersch, 1998, Administration of interleukin-1 at birth affects dopaminergic neurons in adult mice, Ann. N. Y. Acad. Sci., 840, 123, 10.1111/j.1749-6632.1998.tb09556.x

Kegel, 2014, Imbalanced kynurenine pathway in schizophrenia, Int. J. Tryptophan. Res., 7, 15, 10.4137/IJTR.S16800

Kerbeshian, 2007, Chain reaction or time bomb: a neuropsychiatric-developmental/neurodevelopmental formulation of tourettisms, pervasive developmental disorder, and schizophreniform symptomatology associated with PANDAS, World J. Biol. Psychiatry, 8, 201, 10.1080/15622970601182652

Kerschensteiner, 2009, Neuro-immune crosstalk in CNS diseases, Neuroscience, 158, 1122, 10.1016/j.neuroscience.2008.09.009

Körschenhausen, 1996, Fibrin degradation products in post mortem brain tissue of schizophrenics: a possible marker for underlying inflammatory processes, Schizophr. Res., 19, 103, 10.1016/0920-9964(95)00073-9

Krause, 2010, The association of infectious agents and schizophrenia, World J. Biol. Psychiatry, 11, 739, 10.3109/15622971003653246

Kutzelnigg, 2005, Cortical demyelination and diffuse white matter injury in multiple sclerosis, Brain, 128, 2705, 10.1093/brain/awh641

Laan, 2010, Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial, J. Clin. Psychiatry, 71, 520, 10.4088/JCP.09m05117yel

Levkovitz, 2010, A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia, J. Clin. Psychiatry, 71, 138, 10.4088/JCP.08m04666yel

Leweke, 2004, Antibodies to infectious agents in individuals with recent onset schizophrenia, Eur. Arch. Psychiatry Clin. Neurosci., 254, 4, 10.1007/s00406-004-0481-6

Linderholm, 2012, Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia, Schizophr. Bull., 38, 426, 10.1093/schbul/sbq086

Ling, 1998, Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines, Exp. Neurol., 149, 411, 10.1006/exnr.1998.6715

Meinl, 2008, Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis, J. Neurol Sci., 274, 42, 10.1016/j.jns.2008.06.032

Meisenzahl, 2001, Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia, Am. J. Psychiatry, 158, 1316, 10.1176/appi.ajp.158.8.1316

Mercadante, 2000, The psychiatric symptoms of rheumatic fever, Am. J. Psychiatry, 157, 2036, 10.1176/appi.ajp.157.12.2036

Meyer, 2009, Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia, Psychopharmacology (Berl)., 206, 587, 10.1007/s00213-009-1504-9

Meyer, 2011, Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond, Pharmacol. Ther., 132, 96, 10.1016/j.pharmthera.2011.06.003

Miller, 2011, Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects, Biol. Psychiatry, 70, 663, 10.1016/j.biopsych.2011.04.013

Mizoguchi, 2008, Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice, Psychopharmacology (Berl)., 196, 233, 10.1007/s00213-007-0955-0

Müller, 2010, COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence, Curr. Opin. Investig. Drugs, 11, 31

Müller, 2014, Immunology of schizophrenia, Neuroimmunomodulation, 21, 109, 10.1159/000356538

Müller, 2013, The mild encephalitis concept for psychiatric disorders revisited in the light of current psychoneuroimmunological findings, Neurol. Psychiatry Brain Res., 19, 87, 10.1016/j.npbr.2013.04.004

Müller, 1993, Cerebral involvement of scleroderma presenting as schizophrenia-like psychosis, Schizophr. Res., 10, 179, 10.1016/0920-9964(93)90054-M

Müller, 1992, Depression as a cerebral manifestation of scleroderma: immunological findings in serum and cerebrospinal fluid, Biol. Psychiatry, 31, 1151, 10.1016/0006-3223(92)90160-2

Müller, 2010, Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment, Schizophr. Res., 121, 119, 10.1016/j.schres.2010.04.015

Müller, 2011, Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspects, Curr. Pharm. Des., 17, 130, 10.2174/138161211795049552

Müller, 2005, Clinical effects of COX-2 inhibitors on cognition in schizophrenia, Eur. Arch. Psychiatry Clin. Neurosci., 255, 149, 10.1007/s00406-004-0548-4

Müller, 2006, Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders, Expert Rev. Neurother., 6, 1017, 10.1586/14737175.6.7.1017

Müller, 2007, The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view, J. Neural. Transm., 269, 10.1007/978-3-211-73574-9_33

Müller, 2010, Immune system and schizophrenia, Curr. Immunol. Rev., 6, 213, 10.2174/157339510791823673

Myint, 2011, Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients, Brain Behav. Immun., 25, 1576, 10.1016/j.bbi.2011.05.005

Nair, 2006, Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation, J. Neuroimmunol., 171, 72, 10.1016/j.jneuroim.2005.09.012

Nikolich-Zugich, 2008, Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections, Nat. Rev. Immunol., 8, 512, 10.1038/nri2318

Nitta, 2013, Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials, Schizophr. Bull., 10.1093/schbul/sbt070

Notarangelo, 2014, Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia, Schizophr. Res., 152, 261, 10.1016/j.schres.2013.11.011

Olsson, 2009, Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia, Int. J. Neuropsychopharmacol., 12, 501, 10.1017/S1461145708009383

O'Neill, 2008, How frustration leads to inflammation, Science, 320, 619, 10.1126/science.1158398

Oommen, 1982, Herpes simplex type 2 virus encephalitis presenting as psychosis, Am. J. Med., 73, 445, 10.1016/0002-9343(82)90751-3

Pearce, 2001, Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms, Mol. Psychiatry, 6, 634, 10.1038/sj.mp.4000956

Perry, 2007, Stress primes microglia to the presence of systemic inflammation: implications for environmental influences on the brain, Brain Behav. Immun., 21, 45, 10.1016/j.bbi.2006.08.004

Potter, 1999, Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons, Cell Tissue Res., 296, 235, 10.1007/s004410051285

Potvin, 2008, Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review, Biol. Psychiatry, 63, 801, 10.1016/j.biopsych.2007.09.024

Rouse, 2010, Immunity and immunopathology to viruses: what decides the outcome?, Nat. Rev. Immunol., 10, 514, 10.1038/nri2802

Rutherford, 2014, Placebo response in antipsychotic clinical trials: a meta-analysis, JAMA Psychiatry, 71, 1409, 10.1001/jamapsychiatry.2014.1319

Sathyasaikumar, 2011, Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia, Schizophr. Bull., 37, 1147, 10.1093/schbul/sbq112

Schwarcz, 2001, Increased cortical kynurenate content in schizophrenia, Biol. Psychiatry, 50, 521, 10.1016/S0006-3223(01)01078-2

Sommer, 2012, Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis, J. Clin. Psychiatry, 73, 414, 10.4088/JCP.10r06823

Sommer, 2014, Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update, Schizophr. Bull., 40, 181, 10.1093/schbul/sbt139

Sørensen, 2009, Association between prenatal exposure to bacterial infection and risk of schizophrenia, Schizophr. Bull., 35, 631, 10.1093/schbul/sbn121

Sparkman, 2008, Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress, Neuroimmunomodulation, 15, 323, 10.1159/000156474

Sperner-Unterweger, 1992, Neopterin production in acute schizophrenic patients: an indicator of alterations of cell-mediated immunity, Psychiatry Res., 42, 121, 10.1016/0165-1781(92)90076-F

Steen, 2006, Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies, Br. J. Psychiatry, 188, 510, 10.1192/bjp.188.6.510

Steiner, 2013, Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis, JAMA Psychiatry, 70, 271, 10.1001/2013.jamapsychiatry.86

Stone, 1993, Neuropharmacology of quinolinic and kynurenic acids, Pharmacol. Rev., 45, 309

Takano, 2010, Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106, Int. J. Neuropsychopharmacol., 13, 943, 10.1017/S1461145710000313

Teixeira, 2007, Psychosis following acute Sydenham's chorea, Eur. Child Adolesc. Psychiatry, 16, 67, 10.1007/s00787-006-0566-z

van Berckel, 2008, Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study, Biol. Psychiatry, 64, 820, 10.1016/j.biopsych.2008.04.025

van Dam, 1991, Diagnosis and pathogenesis of CNS lupus, Rheumatol. Int., 11, 1, 10.1007/BF00290244

Versijpt, 2003, Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study, Eur. Neurol., 50, 39, 10.1159/000070857

Vincent, 2008, Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults, Lancet Neurol., 7, 1074, 10.1016/S1474-4422(08)70225-4

Westergaard, 1999, Exposure to prenatal and childhood infections and the risk of schizophrenia: suggestions from a study of sibship characteristics and influenza prevalence, Arch. Gen. Psychiatry, 56, 993, 10.1001/archpsyc.56.11.993

Wildenauer, 1991, Analysis of cerebrospinal fluid from patients with psychiatric and neurological disorders by two-dimensional electrophoresis: identification of disease-associated polypeptides as fibrin fragments, Electrophoresis, 12, 487, 10.1002/elps.1150120706

Winter, 2009, Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia, Int. J. Neuropsychopharmacol., 12, 513, 10.1017/S1461145708009206

Yolken, 1995, Viruses, schizophrenia, and bipolar disorder, Clin. Microbiol. Rev., 8, 131, 10.1128/CMR.8.1.131

Zhou, 1993, Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis, Endocrinology, 133, 2523, 10.1210/endo.133.6.8243274

Zubin, 1977, Vulnerability–a new view of schizophrenia, J. Abnorm. Psychol., 86, 103, 10.1037/0021-843X.86.2.103